Trial intelligence / Profile preview

Telbivudine to Prevent Mother-to-Child Transmission of HBV in Pregnant Women

ChiCTR-OPC-16008318Phase 4Completed

Sponsor
First Affiliated Hospital of Jinan University
Start
Sep 2011
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4 trial of telbivudine in Chronic Hepatitis B (CHB) and hepatitis B (HBV) (2 arms), sponsored by First Affiliated Hospital of Jinan University. Primary endpoints: Serum markers for hepatitis B, HBV DNA level and 3 more. Started Sep 2011; status: completed.

02

Drugs

telbivudine
03

Conditions

Chronic Hepatitis B (CHB)hepatitis B (HBV)

Beyond the preview

Go deeper on ChiCTR-OPC-16008318.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-OPC-16008318.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call